Skip to content
ARON 3D_Transparent
  • Home
  • About Us
  • Contributors
  • Publications
    • Aron 1 – Renal Cell Carcinoma
    • Aron 2 – Urothelial carcinoma
    • Aron 3 – Prostate Cancer
    • Aron – supplementaries
  • Contact Us​
Menu
  • Home
  • About Us
  • Contributors
  • Publications
    • Aron 1 – Renal Cell Carcinoma
    • Aron 2 – Urothelial carcinoma
    • Aron 3 – Prostate Cancer
    • Aron – supplementaries
  • Contact Us​

Category: Publications

wealth of knowledge in the field of healthcare and medicine. Discover a curated selection of articles, research papers, and resources authored by esteemed professionals and leading experts in the medical community. From groundbreaking discoveries to practical insights and clinical guidelines, delve into the latest advancements, case studies, and discussions shaping the future of healthcare. Whether you’re a healthcare professional, student, or simply passionate about staying informed, explore our collection to expand your understanding and stay up-to-date with the latest trends and developments in the medical world.

Geographical Differences in the Management and Outcomes of PatientsWith Advanced Urothelial Carcinoma Treated With Pembrolizumab AfterProgression on Platinum-Based Chemotherapy: Results From ARON-2Study

Geo diff

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients withmetastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

Cabo nivo vs pembro axi

Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell RenalCell Carcinoma: Results from the ARON-1 Study

non clear

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study

nivo cabo

mRNA expression, tumor heterogeneity, and response to therapy inpatients with advanced renal cell carcinoma treated with immune-basedcombinations (ARON-1α)

mRNA ARON 1

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study

Progetto senza titolo 2

Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study. 

8NFEVBrIQXOyNoE ypuJ Q

Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project 

I Q98Jc2TzefKFMEqz 1lw 1

Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project 

s4a1nnQeTsCmTjf dmcS8w

Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study

liqY6DfIRZ2ExhcXktzYsg
Next →

Do you want to join us ?

Join us today
ARON 3D_Transparent
Youtube Linkedin

Coordinated and designed by Atteggiamento Digitale .

Legal and Privacy.